TACTOGEN Trademark

Trademark Overview

On Friday, September 25, 2020, a trademark application was filed for TACTOGEN with the United States Patent and Trademark Office. The USPTO has given the TACTOGEN trademark a serial number of 90211973. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Tactogen Inc. The TACTOGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a website featuring educational information in the field of clinical research; Scientific research; Testing of pharmaceuticals
tactogen

General Information

Serial Number90211973
Word MarkTACTOGEN
Filing DateFriday, September 25, 2020
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7287643
Registration DateTuesday, January 23, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements

Description of MarkThe mark consists of the design of a single-line hexagon with parallel left and right sides and its bottom vertex being a greater distance from the center than its top vertex. To the right of this design appears the wording "TACTOGEN" in stylized font.
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a website featuring educational information in the field of clinical research; Scientific research; Testing of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 6, 2020
Primary Code042
First Use Anywhere DateThursday, April 22, 2021
First Use In Commerce DateThursday, April 22, 2021

Trademark Owner History

Party NameTactogen Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameTactogen Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameTactogen Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, December 18, 2023EXAMINER'S AMENDMENT ENTERED
Monday, December 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 18, 2023EXAMINERS AMENDMENT E-MAILED
Monday, December 18, 2023SU-EXAMINER'S AMENDMENT WRITTEN
Monday, July 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 24, 2023NON-FINAL ACTION E-MAILED
Monday, July 24, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, July 12, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 14, 2023USE AMENDMENT FILED
Tuesday, July 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 14, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, December 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2022SOU EXTENSION 3 GRANTED
Thursday, December 15, 2022SOU EXTENSION 3 FILED
Thursday, December 15, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2022SOU EXTENSION 2 GRANTED
Wednesday, June 15, 2022SOU EXTENSION 2 FILED
Wednesday, June 15, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 15, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 1 FILED
Wednesday, December 15, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 16, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, February 16, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 16, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, February 16, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, February 15, 2021ASSIGNED TO EXAMINER
Saturday, November 7, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, November 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 29, 2020NEW APPLICATION ENTERED

Related Keywords

tactogen pharmaceutical research development pharmaceuticals field information providing scientific clinical featuring